HOUSTON (CBS HOUSTON) – In a press release on Tuesday the Houston Texans announced that they have placed offensive tackle David Quessenberry on the NFL’s Non-Football Illness List after he was diagnosed with lymphoma this week.
Quessenberry experienced fatigue and a cough over the last week of OTAs and went for medical assistance, that when he was diagnosed with the disease. He is currently being treated at M.D. Anderson Hospital.
“Our medical community here in Houston is the best in the world,” Executive Vice President and General Manager Rick Smith said in a press release. “We are extremely confident in the care and treatment David will receive. He is a fighter and a courageous young man and we look forward to his full and complete recovery. We will continue to support him and his family and look forward to his return to the team. “
Quessenberry missed all of his rookie year in 2013 with an injury sustained in training camp.
UPDATE: David Quessenberry’s agency, Rep1Sports released a full statement regarding the tackle:
It is with a heavy heart that we must announce that a member of our REP 1 Family has been diagnosed with Lymphoma. Houston Texans 23-year-old offensive lineman, David Quessenberry, will be leaving the game for an extended period of time while he undergoes treatment for Non-Hodgkins T Lymphoblastic Lymphoma.
David was diagnosed with the illness last Tuesday. He believed he had been suffering from a chest cold when he experienced shortness of breath at a Texans practice on June 3rd. David was admitted to MD Anderson Cancer Center in Houston later that day, where he immediately began treatment that evening.
The goal of David’s treatment is to cure the disease, so he can return to the life that he has worked so hard to earn. David is extremely positive and determined to win this fight against cancer. Our love for David is strong and we are praying for him and his family during this difficult time. All of your positive thoughts and prayers for David are encouraged and appreciated.
LATEST SPORTS STORIES: